diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state
DIABETIC KETOACIDOSIS & HYPEROSMOLAR HYPERGLYCEMIC STATE
Diabetic ketoacidosis is characterized by having blood glucose >13.9 mmol/L, arterial pH <7.3 in adults or venous pH <7.3 in pediatrics, bicarbonate <15 mEg/L, moderate ketonuria or ketonemia and anion gap >14.
Hyperosmolar hyperglycemic state in adults is described as having blood glucose >33.3 mmol/L, arterial pH >7.3, bicarbonate >15 mEq/L, mild ketonuria or ketonemia, effective serum osmolality >320 mOsm/kg and variable anion gap.
Hyperosmolar hyperglycemic state in pediatric patients has blood glucose >33.3 mmol/L, venous pH >7.3, bicarbonate >15 mEq/L and altered mental status or severe dehydration.

Diabetic%20ketoacidosis%20-and-%20hyperosmolar%20hyperglycemic%20state Diagnosis

Evaluation

Diagnostic Criteria for diabetic ketoacidosis (DKA)

  • Blood glucose >13.9 mmol/L (>250 mg/dL)
  • Arterial pH <7.3 in adults or venous pH <7.3 in pediatrics
  • Bicarbonate <15 mEq/L
  • Moderate ketonuria or ketonemia
  • Anion gap >12

Diagnostic Criteria for hyperosmolar hyperglycemic state (HHS) in Adults

  • Blood glucose >33.3 mmol/L (>600 mg/dL)
  • Arterial pH >7.3
  • Bicarbonate >15 mEq/L
  • Mild ketonuria or ketonemia
  • Effective serum osmolality >320 mOsm/kg
  • Anion gap variable

Diagnostic Criteria for HHS in Pediatrics

  • Blood glucose >33.3 mmol/L (>600 mg/dL)
  • Venous pH >7.3
  • Bicarbonate >15 mEq/L
  • Altered mental status or severe dehydration

Classification

Classification of Diabetic Ketoacidosis

  • Mild DKA presents without alteration in sensorium, > 250 mg/dL plasma glucose, arterial pH 7.25-7.30, 15-18 mEq/L serum bicarbonate, presence of serum & urine ketones, & >10 anion gap
  • Moderate DKA presents w/ or without alteration in sensorium or drowsiness, >250 mg/dL plasma glucose, arterial pH 7-<7.24, 10-<15 mEq/mL serum bicarbonate, presence of serum & urine ketones, & >12 anion gap
  • Severe DKA presents w/ stupor or coma, >250 mg/dL plasma glucose, arterial pH <7, <10 mEq/L serum bicarbonate, presence of serum & urine ketones, & >12 anion gap

History

  • History of polyuria, polydipsia, polyphagia, weight loss, vomiting, abdominal pain (in DKA)
  • Dehydration
  • Weakness

Physical Examination

  • Altered mental status or sensoria clouding to coma (more frequent in HHS)
  • Poor skin turgor, dry axilla & oral mucosa, Kussmaul respirations (in DKA), low jugular venous pressure, tachycardia, hypotension, shock

Laboratory Tests

  • Serum glucose
  • Blood urea nitrogen (BUN)/creatinine
  • Serum ketones
  • Electrolytes (anion gap)
  • Serum osmolality
    • Effective osmolality = (2 × Na) + (glucose/18) 
  • Urinalysis
  • ECG &/or chest X-ray (CXR), if indicated
  • Urine ketones by dipstick
  • Arterial blood gas
  • CBC w/ differential
  • Urine, blood & throat culture
  • Glycosylated hemoglobin (HbA1c)
  • Nitroprusside testing
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elaine Soliven, 4 days ago

Switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF) to the new bictegravir/ emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen maintained high rates of virological suppression in adults who are living with HIV*, according to a study presented at AIDS 2020.

3 days ago
Among individuals with abdominal obesity, drinking beverages with artificial sweeteners (ASBs) or no sugar (USBs) instead of sugar-sweetened beverages (SSBs) helps lose body weight, a study has found. However, USBs have a more favourable effect on sweet taste preference compared with ASBs.
Stephen Padilla, 5 days ago
Pre-exposure prophylaxis (PrEP) containing either long-acting injectable cabotegravir (CAB) or tenofovir/emtricitabine (TDF/FTC) is safe and effective for transgender women (TGW) and cisgender men who have sex with men (MSM), but CAB results in a much lower HIV incidence compared to TDF/FTC, results of the HIV Prevention Trials Network (HPTN) 083 have shown.
Jairia Dela Cruz, 4 days ago
Monthly prophylaxis with the fixed-dose combination of naphthoquine-azithromycin (NQAZ) is well tolerated and confers significant protection against infection with Plasmodium parasites among individuals residing in malaria-endemic areas in Southeast Asia, as shown in the results of a phase III trial.